[1]
Payne, A. and Oh, S. 2023. MuSK-CAART: A novel precision cellular therapy for muscle-specific tyrosine kinase myasthenia gravis : Precision cellular therapy for MuSK myasthenia gravis. RRNMF Neuromuscular Journal. 4, 3 (Aug. 2023). DOI:https://doi.org/10.17161/rrnmf.v4i3.19417.